Federal Register Notice: FDA is making available a guidance for industry, New Contrast Imaging Indication Considerations for Devices and Approved Drug and Biological Products, dated 12/09. FDA intends to help developers of medical imaging devices and imaging drug/biological products that provide image contrast enhancement. The document supercedes a 9/30/08 draft guidance of the same title. To download this guidance, click here. To view this notice, click here.
